Bionest Partners Finance
  • EXPERTISE
    • Levée de fonds
    • Partenariat
    • Fusion & Acquisition
    • Conseil en valorisation
  • PRÉSENTATION
  • TRANSACTIONS
  • CONTACT
  • EN
  • FR
Sélectionner une page

TRANSACTIONS

Récentes Transactions

2021 : Novadip 21M€ series B1 financing

2021 : Novadip 21M€ series B1 financing

2021 : Robocath secures 15M€ financing with EIB

2021 : Robocath secures 15M€ financing with EIB

2020 : Robocath 40M€ series C financing

2020 : Robocath 40M€ series C financing

2020 : European Licensing-out Advisory for Catabasis Pharmaceuticals

2020 : European Licensing-out Advisory for Catabasis Pharmaceuticals

2019 : Beaver Visitec acquires Arcadophta

2019 : Beaver Visitec acquires Arcadophta

2019 : FineHeart 5M€ bridge financing

2019 : FineHeart 5M€ bridge financing

2019 : Senior Assist 20M€ growth financing

2019 : Senior Assist 20M€ growth financing

2018 : Endo-Pharmaceuticals acquires Bioprojet’s Wakix commercial rights in Canada

2018 : Endo-Pharmaceuticals acquires Bioprojet’s Wakix commercial rights in Canada

2018 : Licensing-out Advisory for Acteon

2018 : Licensing-out Advisory for Acteon

2017 : Harmony Biosciences acquires Bioprojet’s Wakix commercial rights in the US

2017 : Harmony Biosciences acquires Bioprojet’s Wakix commercial rights in the US

2016 : M&A Buy Side Advisory for Vifor Pharmaceuticals in European specialty pharma transaction

2016 : M&A Buy Side Advisory for Vifor Pharmaceuticals in European specialty pharma transaction

2016 : AFM Telethon sells Trophos’ Olesoxime commercial rights to Roche Pharmaceuticals

2016 : AFM Telethon sells Trophos’ Olesoxime commercial rights to Roche Pharmaceuticals

2016 : Licensing-out Advisory for Intsel Chimos

2016 : Licensing-out Advisory for Intsel Chimos

Bionest Partners Finance a réalisé un grand nombre de projets de conseil financier pour des startups Healthtech et des sociétés pharmaceutiques spécialisées (fairness opinion, business plan, deal structuration).

  • Suivre